Resultats de la cerca - Martin Gramatzki

Refinar resultats
  1. 1
    Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor

    Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor per Roland Repp, Thomas Valerius, A. Sendler, Martin Gramatzki, Heinrich Iro, JR Kalden, E Platzer

    Publicat 1991
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Human Herpesvirus Type 8 Interleukin-6 Homologue Is Functionally Active on Human Myeloma Cells

    Human Herpesvirus Type 8 Interleukin-6 Homologue Is Functionally Active on Human Myeloma Cells per Renate Burger, Frank Neipel, Bernhard Fleckenstein, Rocco Savino, Gennaro Ciliberto, Joachim R. Kalden, Martin Gramatzki

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy per Thomas Valerius, Roland Repp, TP de Wit, Berthold Seitz, E Platzer, JR Kalden, Martin Gramatzki, JG van de Winkel

    Publicat 1993
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

    CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia per Naoki Hosen, Christopher Y. Park, Naoya Tatsumi, Yusuke Oji, Haruo Sugiyama, Martin Gramatzki, Alan M. Krensky, Irving L. Weissman

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells

    Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells per Hans‐Heinrich Oberg, Christian Kellner, Daniel Gonnermann, Susanne Sebens, Dirk Bauerschlag, Martin Gramatzki, Dieter Kabelitz, Matthias Peipp, Daniela Wesch

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy per Thomas Valerius, Roland Repp, TP de Wit, Berthold Seitz, E Platzer, JR Kalden, Martin Gramatzki, JG van de Winkel

    Publicat 1993
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

    Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing per Michael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, Roland Repp, Martin J. Glennie, Martin Gramatzki, Jan G. J. van de Winkel, Thomas Valerius

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation

    Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation per Katja Brocke-Heidrich, A. Kretzschmar, Gabriele Pfeifer, Christian Henze, Dennis Löffler, Dirk Koczan, Hans‐Jürgen Thiesen, Renate Burger, Martin Gramatzki, Friedemann Horn

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    The bisphosphonate zoledronic acid has antimyeloma activity <i>in vivo</i> by inhibition of protein prenylation

    The bisphosphonate zoledronic acid has antimyeloma activity <i>in vivo</i> by inhibition of protein prenylation per Andreas Guenther, Sharon Gordon, Markus Tiemann, Renate Burger, Frank Bakker, Jonathan R. Green, Wolfgang Baum, Anke J. Roelofs, Michael J. Rogers, Martin Gramatzki

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor

    HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor per David Elsässer, Thomas Valerius, Roland Repp, George J. Weiner, Yashwant M. Deo, JR Kalden, JG van de Winkel, GT Stevenson, MJ Glennie, Martin Gramatzki

    Publicat 1996
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Phase II trial of zanolimumab (HuMax‐CD4) in relapsed or refractory non‐cutaneous peripheral T cell lymphoma

    Phase II trial of zanolimumab (HuMax‐CD4) in relapsed or refractory non‐cutaneous peripheral T cell lymphoma per Francesco d’Amore, John Radford, Thomas Relander, Mats Jerkeman, Hervé Tilly, Anders Österborg, Franck Morschhauser, Martin Gramatzki, Martin Dreyling, B K Bang, Hans Hagberg

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

    IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial per Jens Atzpodien, Hartmut Kirchner, H.J. Illiger, Bernd Metzner, D. Ukena, Harold C. Schott, P.-J. Funke, Martin Gramatzki, S von Jürgenson, T Wandert, T Patzelt, Martina Reitz

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity

    Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity per Christian Kellner, Tina Maurer, Daniela Hallack, Roland Repp, Jan G. J. van de Winkel, Paul W.H.I. Parren, Thomas Valerius, Andreas Humpe, Martin Gramatzki, Matthias Peipp

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT

    Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT per Avichai Shimoni, Myriam Labopin, Jürgen Finke, Fabio Ciceri, Éric Deconinck, Nicolaus Kröger, Martin Gramatzki, Matthias Stelljes, Didier Blaise, Friedrich Stoelzel, Patrice Chevallier, Ernst Holler, Nathalie Fegueux, Mohamad Mohty, Arnon Nagler

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

    Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer per Dennis Löffler, Katja Brocke-Heidrich, Gabriele Pfeifer, Claudia Stocsits, Jörg Hackermüller, A. Kretzschmar, Renate Burger, Martin Gramatzki, Conny Blumert, Kay Bauer, Helena Cvijic, A. Kerstin Ullmann, Peter F. Stadler, Friedemann Horn

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working P... per Anna Sureda, Stephen Robinson, Carmen Canals, Angelo Michele Carella, Marc Boogaerts, Dolores Caballero, Ann E. Hunter, Lothar Kanz, Shimon Slavin, Jan J. Cornelissen, Martin Gramatzki, Dietger Niederwieser, Nigel H. Russell, Norbert Schmitz

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

    Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II stud... per Wolfram Brugger, Joy Hirsch, Frank Grünebach, Roland Repp, Peter Brossart, Wichard Vogel, Hans‐Georg Kopp, Markus G. Manz, Michael Bitzer, Günter Schlimok, Martin Kaufmann, Arnold Ganser, K. Fehnle, Martin Gramatzki, Lothar Kanz

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy

    Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy per Bernhard Stockmeyer, Michael Dechant, Marjolein van Egmond, Alison L. Tutt, Karuna Sundarapandiyan, Robert F. Graziano, Roland Repp, Joachim R. Kalden, Martin Gramatzki, Martin J. Glennie, Jan G. J. van de Winkel, Thomas Valerius

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells

    Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells per Hans‐Heinrich Oberg, Matthias Peipp, Christian Kellner, Susanne Sebens, Sarah Krause, Domantas Petrick, Sabine Adam‐Klages, Christoph Röcken, Thomas Becker, Ilka Vogel, D. Weisner, Sandra Freitag‐Wolf, Martin Gramatzki, Dieter Kabelitz, Daniela Wesch

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial per Thomas Elter, Peter Borchmann, H. Schulz, Marcel Reiser, Sven Trelle, Roland Schnell, Markus Jensen, Peter Staib, Timo Schinköthe, H. Stützer, Jürgen Rech, Martin Gramatzki, Walter E. Aulitzky, Ibrahim Hasan, Andreas Josting, Michael Hallek, Andreas Engert

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: